These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26440467)

  • 1. Preadmission treatment with sulfonylureas and infarct size after ST-elevation myocardial infarction.
    Eyuboglu M
    Int J Cardiol; 2016 Jan; 202():519. PubMed ID: 26440467
    [No Abstract]   [Full Text] [Related]  

  • 2. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.
    Sciagrà R; Parodi G; Migliorini A; Valenti R; Antoniucci D; Sotgia B; Pupi A
    Am J Cardiol; 2006 Jan; 97(1):48-54. PubMed ID: 16377283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dobutamine-induced ST-segment elevation associated with a biphasic response of wall motion in patients with a recent myocardial infarction is caused by myocardial ischaemia and is abolished by revascularization of the infarct-related artery.
    Lanzarini L; Scelsi L; Canosi U; Klersy C; Sebastiani R; Previtali M
    Acta Cardiol; 2003 Dec; 58(6):527-33. PubMed ID: 14713178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty.
    Tzivoni D; Koukoui D; Guetta V; Novack L; Cowing G;
    Am J Cardiol; 2008 Mar; 101(6):753-7. PubMed ID: 18328834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.
    Spacek R; Widimský P; Straka Z; Jiresová E; Dvorák J; Polásek R; Karel I; Jirmár R; Lisa L; Budesínský T; Málek F; Stanka P
    Eur Heart J; 2002 Feb; 23(3):230-8. PubMed ID: 11792138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial.
    Hahn JY; Song YB; Kim EK; Yu CW; Bae JW; Chung WY; Choi SH; Choi JH; Bae JH; An KJ; Park JS; Oh JH; Kim SW; Hwang JY; Ryu JK; Park HS; Lim DS; Gwon HC
    Circulation; 2013 Oct; 128(17):1889-96. PubMed ID: 24068776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac MRI evaluation of infarct size with thrombus aspiration during ST-segment elevation myocardial infarction.
    Varshney A; Martinez-Rumayor AA; Brilakis ES; Banerjee S
    J Invasive Cardiol; 2011 May; 23(5):177-8. PubMed ID: 21562343
    [No Abstract]   [Full Text] [Related]  

  • 9. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size.
    Nijveldt R; van der Vleuten PA; Hirsch A; Beek AM; Tio RA; Tijssen JG; Piek JJ; van Rossum AC; Zijlstra F
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1187-94. PubMed ID: 19833308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of acute myocardial infarct with ST segment elevation].
    Nordt TK; Bode Ch
    Ther Umsch; 2002 Feb; 59(2):79-81. PubMed ID: 11887553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Hahn JY; Kim HJ; Choi YJ; Jo SH; Kim HJ; Lee S; Ahn KJ; Song YB; Choi JH; Choi SH; Choi YJ; Lee KH; Lee SH; Gwon HC
    Am Heart J; 2011 Dec; 162(6):1026-33. PubMed ID: 22137076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.
    Stone GW; Martin JL; de Boer MJ; Margheri M; Bramucci E; Blankenship JC; Metzger DC; Gibbons RJ; Lindsay BS; Weiner BH; Lansky AJ; Krucoff MW; Fahy M; Boscardin WJ;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):366-75. PubMed ID: 20031745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction.
    Chia S; Nagurney JT; Brown DF; Raffel OC; Bamberg F; Senatore F; Wackers FJ; Jang IK
    Am J Cardiol; 2009 Feb; 103(3):333-7. PubMed ID: 19166685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.
    De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F;
    J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):815-20. PubMed ID: 23519096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction.
    Hallén J; Jensen JK; Buser P; Jaffe AS; Atar D
    Acute Card Care; 2011 Mar; 13(1):48-51. PubMed ID: 21244230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
    Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Door-to-Balloon Time as a Process Metric for Treatment of ST-Segment Elevation Myocardial Infarction: Time to "Tap Out"?
    Kutcher MA
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1975-1977. PubMed ID: 26738668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
    Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
    Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.